Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
3.
Pediátr. Panamá ; 52(3): 131-136, 18 de diciembre de 2023.
Artículo en Español | LILACS-Express | LILACS | ID: biblio-1523417

RESUMEN

Se presenta el caso de una recién nacida a término valorada en el servicio de urgencias por ictericia sin criterios de fototerapia. En los controles analíticos posteriores se detecta hipertransaminasemia y dislipemia con aumento de LDL-colesterol. Tras no objetivar alteraciones en los diferentes parámetros estudiados se realiza biopsia hepática que muestra hallazgos compatibles con cirrosis. Se amplía el estudio metabólico y presenta un perfil alterado de sialotransferrinas lo que lleva a realizar un diagnóstico de defecto congénito de la glicosilación. Bajo este nombre se incluye un grupo amplio de enfermedades relacionadas con alteraciones en el proceso de unión de glicanos a las cadenas proteicas. Este defecto, de origen genético, implica cambios en la estructura y funcionalidad de las glicoproteínas. Las manifestaciones clínicas son heterogéneas, en función del gen afecto y del tipo de glicoproteínas alteradas, siendo lo más común la afectación hepática, neurológica y hematológica. (provisto por Infomedic International)


We present the case of a full-term newborn girl evaluated in the emergency department for jaundice without phototherapy criteria. Subsequent laboratory tests showed hypertransaminasemia and dyslipidemia with increased LDL-cholesterol. After finding no alterations in the different parameters studied, a liver biopsy was performed showing findings compatible with cirrhosis. The metabolic study was extended and the patient presented an altered sialotransferrin profile, which led to a diagnosis of congenital defect of glycosylation. This name includes a broad group of diseases related to alterations in the process of glycan binding to protein chains. This defect, of genetic origin, involves changes in the structure and functionality of glycoproteins. The clinical manifestations are heterogeneous, depending on the gene affected and the type of glycoproteins altered, the most common being hepatic, neurological and hematological involvement. (provided by Infomedic International)

5.
Arch Dermatol Res ; 314(4): 369-378, 2022 May.
Artículo en Inglés | MEDLINE | ID: mdl-33973061

RESUMEN

Several authors have studied the potential of sentinel lymph node (SLN) tumor burden as prognostic factor but the microscopic classifications used in different study groups were variable. We examined the prognostic role of tumor burden in SLN on melanoma specific-survival and competing causes of death. We also analysed clinical and histological factors as predictors of disease relapses and additional non sentinel lymph node (NSLN) metastases. We included all patients with cutaneous melanoma that underwent SLN biopsy between 2002 and 2012 at Complejo Hospitalario de Navarra (Spain). The study end-points were death due to melanoma, melanoma relapse and involvement of NSLN. We used Fine-Gray test for competing risk analysis. A logistic regression model was performed to predict the risk of involvement of NSLN. Between 2002 and 2012, there were 348 patients who underwent SLN biopsy in our centre (308 were eligible for the study). 26.9% patients positive SLN. 88 patients died during the follow-up period and 66 (75%) died from melanoma. The 5-year cumulative incidence of melanoma death was 15.33% (95 % CI 15.25-15.42). The cumulative probability of death from melanoma was associated with gender, histological subtype, Breslow thickness, mitotic rate, ulceration and SLN tumor burden. In multivariable analysis, Breslow thickness and SLN tumor burden remained as independent prognostic factors. SLN tumor burden appears to be an important prognostic factor. It is very important reporting these characteristics in pathological reports. More prospective studies would be necessary to analyze these variables and to be able to make recommendations in management of melanoma patients.


Asunto(s)
Melanoma , Ganglio Linfático Centinela , Neoplasias Cutáneas , Estudios de Seguimiento , Humanos , Metástasis Linfática , Melanoma/patología , Recurrencia Local de Neoplasia/epidemiología , Pronóstico , Estudios Prospectivos , Estudios Retrospectivos , Medición de Riesgo , Ganglio Linfático Centinela/patología , Neoplasias Cutáneas/patología , Carga Tumoral , Melanoma Cutáneo Maligno
8.
Gastroenterol. hepatol. (Ed. impr.) ; 41(3): 175-190, mar. 2018. tab
Artículo en Español | IBECS | ID: ibc-171133

RESUMEN

Este documento resume el contenido de la Guía de resección mucosa endoscópica elaborada por el grupo de trabajo de la Sociedad Española de Endoscopia Digestiva (GSEED de Resección Endoscópica) y expone las recomendaciones sobre el manejo endoscópico de las lesiones neoplásicas colorrectales superficiales (AU)


This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions (AU)


Asunto(s)
Humanos , Masculino , Femenino , Resección Endoscópica de la Mucosa/métodos , Neoplasias Colorrectales/diagnóstico por imagen , Neoplasias Colorrectales/cirugía , Resección Endoscópica de la Mucosa/instrumentación , Resección Endoscópica de la Mucosa/normas , Neoplasias Colorrectales/economía
9.
Rev. esp. enferm. dig ; 110(3): 179-194, mar. 2018. tab
Artículo en Español | IBECS | ID: ibc-171520

RESUMEN

Este documento resume el contenido de la Guía de resección mucosa endoscópica elaborada por el grupo de trabajo de la Sociedad Española de Endoscopia Digestiva (GSEED de Resección Endoscópica) y expone las recomendaciones sobre el manejo endoscópico de las lesiones neoplásicas colorrectales superficiales (AU)


This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions (AU)


Asunto(s)
Humanos , Neoplasias Colorrectales/cirugía , Endoscopía Gastrointestinal/métodos , Resección Endoscópica de la Mucosa/métodos , Mucosa Intestinal/patología , Revisión por Pares , Selección de Paciente , Cuidados Preoperatorios/métodos , Colonoscopía/métodos
10.
Rev Esp Enferm Dig ; 110(3): 179-194, 2018 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-29421912

RESUMEN

This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions.


Asunto(s)
Neoplasias Colorrectales/cirugía , Cirugía Colorrectal/métodos , Resección Endoscópica de la Mucosa/métodos , Endoscopía Gastrointestinal/métodos , Mucosa Intestinal/cirugía , Enfermedades del Colon/cirugía , Cirugía Colorrectal/normas , Resección Endoscópica de la Mucosa/normas , Endoscopía Gastrointestinal/normas , Humanos , Enfermedades del Recto/cirugía
11.
Gastroenterol Hepatol ; 41(3): 175-190, 2018 Mar.
Artículo en Inglés, Español | MEDLINE | ID: mdl-29449039

RESUMEN

This document summarizes the contents of the Clinical Guidelines for the Endoscopic Mucosal Resection of Non-Pedunculated Colorectal Lesions that was developed by the working group of the Spanish Society of Digestive Endoscopy (GSEED of Endoscopic Resection). This document presents recommendations for the endoscopic management of superficial colorectal neoplastic lesions.


Asunto(s)
Neoplasias Colorrectales/cirugía , Resección Endoscópica de la Mucosa/normas , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...